KDM7A and neoplasm: Our findings suggest that KDM7A-DT expression can be altered by some specific driver mutation(s) in susceptible tumor gene(s), including TP53. According to data, TP53-mutation mRNA could be overexpressed compared with the wild-type samples, and missense mutations may be driver mutations in BRCA.